Horizon Therapeutics

E1614218 UNEXPLORED

Horizon Therapeutics is a biopharmaceutical company focused on developing and commercializing medicines for rare, autoimmune, and severe inflammatory diseases.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label	Occurrences
Horizon Therapeutics canonical	3

Referenced by (3)

Full triples — surface form annotated when it differs from this entity's canonical label.

Irish Open → sponsor → Horizon Therapeutics ⓘ

Amgen → acquired → Horizon Therapeutics ⓘ

Teprotumumab → hasDeveloper → Horizon Therapeutics ⓘ